These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 30036051)

  • 1. Cichoric Acid Prevents Free-Fatty-Acid-Induced Lipid Metabolism Disorders via Regulating Bmal1 in HepG2 Cells.
    Guo R; Zhao B; Wang Y; Wu D; Wang Y; Yu Y; Yan Y; Zhang W; Liu Z; Liu X
    J Agric Food Chem; 2018 Sep; 66(37):9667-9678. PubMed ID: 30036051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Water Extract of Dolichos lablab Attenuates Hepatic Lipid Accumulation in a Cellular Nonalcoholic Fatty Liver Disease Model.
    Im AR; Kim YH; Lee HW; Song KH
    J Med Food; 2016 May; 19(5):495-503. PubMed ID: 27152979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of
    Mun J; Park J; Yoon HG; You Y; Choi KC; Lee YH; Kim K; Lee J; Kim OK; Jun W
    J Med Food; 2019 Dec; 22(12):1262-1270. PubMed ID: 31834842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alisol A 24-Acetate Prevents Hepatic Steatosis and Metabolic Disorders in HepG2 Cells.
    Zeng L; Tang W; Yin J; Feng L; Li Y; Yao X; Zhou B
    Cell Physiol Biochem; 2016; 40(3-4):453-464. PubMed ID: 27889747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol Maintains Lipid Metabolism Homeostasis via One of the Mechanisms Associated with the Key Circadian Regulator Bmal1.
    Li J; Wei L; Zhao C; Li J; Liu Z; Zhang M; Wang Y
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31408938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of herbal composition Gambigyeongsinhwan (4) on hepatic steatosis and inflammation in Otsuka Long-Evans Tokushima fatty rats and HepG2 cells.
    Yoon S; Kim J; Lee H; Lee H; Lim J; Yang H; Shin SS; Yoon M
    J Ethnopharmacol; 2017 Jan; 195():204-213. PubMed ID: 27845265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palmitate-induced Regulation of PPARγ via PGC1α: a Mechanism for Lipid Accumulation in the Liver in Nonalcoholic Fatty Liver Disease.
    Maruyama H; Kiyono S; Kondo T; Sekimoto T; Yokosuka O
    Int J Med Sci; 2016; 13(3):169-78. PubMed ID: 26941577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nobiletin protects against insulin resistance and disorders of lipid metabolism by reprogramming of circadian clock in hepatocytes.
    Qi G; Guo R; Tian H; Li L; Liu H; Mi Y; Liu X
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Jun; 1863(6):549-562. PubMed ID: 29501626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of cichoric acid on H
    Ma J; Li M; Kalavagunta PK; Li J; He Q; Zhang Y; Ahmad O; Yin H; Wang T; Shang J
    Biomed Pharmacother; 2018 Aug; 104():679-685. PubMed ID: 29803928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mulberry anthocyanins inhibit oleic acid induced lipid accumulation by reduction of lipogenesis and promotion of hepatic lipid clearance.
    Chang JJ; Hsu MJ; Huang HP; Chung DJ; Chang YC; Wang CJ
    J Agric Food Chem; 2013 Jun; 61(25):6069-76. PubMed ID: 23731091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chicoric acid attenuate a nonalcoholic steatohepatitis by inhibiting key regulators of lipid metabolism, fibrosis, oxidation, and inflammation in mice with methionine and choline deficiency.
    Kim M; Yoo G; Randy A; Kim HS; Nho CW
    Mol Nutr Food Res; 2017 May; 61(5):. PubMed ID: 27981809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-Caryophyllene attenuates palmitate-induced lipid accumulation through AMPK signaling by activating CB2 receptor in human HepG2 hepatocytes.
    Kamikubo R; Kai K; Tsuji-Naito K; Akagawa M
    Mol Nutr Food Res; 2016 Oct; 60(10):2228-2242. PubMed ID: 27234712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Puerarin ameliorates hepatic steatosis by activating the PPARα and AMPK signaling pathways in hepatocytes.
    Kang OH; Kim SB; Mun SH; Seo YS; Hwang HC; Lee YM; Lee HS; Kang DG; Kwon DY
    Int J Mol Med; 2015 Mar; 35(3):803-9. PubMed ID: 25605057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the new thiazolidine derivative LPSF/GQ-02 on hepatic lipid metabolism pathways in non-alcoholic fatty liver disease (NAFLD).
    Araújo S; Soares E Silva A; Gomes F; Ribeiro E; Oliveira W; Oliveira A; Lima I; Lima MDC; Pitta I; Peixoto C
    Eur J Pharmacol; 2016 Oct; 788():306-314. PubMed ID: 27349145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rutin exhibits hepatoprotective effects in a mouse model of non-alcoholic fatty liver disease by reducing hepatic lipid levels and mitigating lipid-induced oxidative injuries.
    Liu Q; Pan R; Ding L; Zhang F; Hu L; Ding B; Zhu L; Xia Y; Dou X
    Int Immunopharmacol; 2017 Aug; 49():132-141. PubMed ID: 28577437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of miR-181a impairs lipid metabolism by targeting PPARα expression in nonalcoholic fatty liver disease.
    Huang R; Duan X; Liu X; Cao H; Wang Y; Fan J; Wang B
    Biochem Biophys Res Commun; 2019 Jan; 508(4):1252-1258. PubMed ID: 30558790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 14-3-3β and γ differentially regulate peroxisome proliferator activated receptor γ2 transactivation and hepatic lipid metabolism.
    Park S; Yoo S; Kim J; An HT; Kang M; Ko J
    Biochim Biophys Acta; 2015 Oct; 1849(10):1237-47. PubMed ID: 26260846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sesamin ameliorates hepatic steatosis and inflammation in rats on a high-fat diet via LXRα and PPARα.
    Zhang R; Yu Y; Hu S; Zhang J; Yang H; Han B; Cheng Y; Luo X
    Nutr Res; 2016 Sep; 36(9):1022-1030. PubMed ID: 27632923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol protects against nonalcoholic fatty liver disease by improving lipid metabolism and redox homeostasis via the PPARα pathway.
    Huang Y; Lang H; Chen K; Zhang Y; Gao Y; Ran L; Yi L; Mi M; Zhang Q
    Appl Physiol Nutr Metab; 2020 Mar; 45(3):227-239. PubMed ID: 31173696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Li-Gan-Shi-Liu-Ba-Wei-San improves non-alcoholic fatty liver disease through enhancing lipid oxidation and alleviating oxidation stress.
    Jiang Y; Chen L; Wang H; Narisi B; Chen B
    J Ethnopharmacol; 2015 Dec; 176():499-507. PubMed ID: 26571089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.